Overview
- 3 inspections across 3 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-05-02.
At a glance
Inspections
3
Sites
3
Observations
0
Career since
Nov 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Precigen Inc | 2 May 2025 | Biologics | |
| Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 10 Nov 2023 | Biologics | On file |
| Krystal Biotech, Inc. | 16 Nov 2022 | Biologics | On file |
Sites inspected
Precigen IncGermantown, United States1 insp.
Wyeth Pharmaceutical Division of Wyeth Holdings LLCSanford, United States1 insp.
Krystal Biotech, Inc.Pittsburgh, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joydeep Ghosh1 shared
Shaina R Fullwood1 shared
Hector A Carrero1 shared
Ronit Jolles-Mazor1 shared
Kevin J Matthews1 shared
Jie He1 shared
Anna R Kwilas1 shared
Carl A Perez1 shared
Bo Liang1 shared
Priscilla M Pastrana1 shared
Full investigator report
Get the verbatim findings behind Jianyang Wang's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site